Pathogenesis of Target Organ Damage in Hypertension: Role of Mitochondrial Oxidative Stress
Hypertension causes target organ damage (TOD) that involves vasculature, heart, brain and kidneys. Complex biochemical, hormonal and hemodynamic mechanisms are involved in the pathogenesis of TOD. Common to all these processes is an increased bioavailability of reactive oxygen species (ROS). Both i...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/16/1/823 |
id |
doaj-c467b97f62174cd3a69384c1669f8896 |
---|---|
record_format |
Article |
spelling |
doaj-c467b97f62174cd3a69384c1669f88962020-11-25T00:55:09ZengMDPI AGInternational Journal of Molecular Sciences1422-00672014-12-0116182383910.3390/ijms16010823ijms16010823Pathogenesis of Target Organ Damage in Hypertension: Role of Mitochondrial Oxidative StressSperanza Rubattu0Beniamino Pagliaro1Giorgia Pierelli2Caterina Santolamazza3Sara Di Castro4Silvia Mennuni5Massimo Volpe6Department of Clinical and Molecular Medicine, School of Medicine and Psychology, University Sapienza of Rome, Ospedale S. Andrea, Rome 00189, ItalyDepartment of Clinical and Molecular Medicine, School of Medicine and Psychology, University Sapienza of Rome, Ospedale S. Andrea, Rome 00189, ItalyDepartment of Clinical and Molecular Medicine, School of Medicine and Psychology, University Sapienza of Rome, Ospedale S. Andrea, Rome 00189, ItalyDepartment of Clinical and Molecular Medicine, School of Medicine and Psychology, University Sapienza of Rome, Ospedale S. Andrea, Rome 00189, ItalyIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Neuromed, Pozzilli 86077, ItalyDepartment of Clinical and Molecular Medicine, School of Medicine and Psychology, University Sapienza of Rome, Ospedale S. Andrea, Rome 00189, ItalyDepartment of Clinical and Molecular Medicine, School of Medicine and Psychology, University Sapienza of Rome, Ospedale S. Andrea, Rome 00189, ItalyHypertension causes target organ damage (TOD) that involves vasculature, heart, brain and kidneys. Complex biochemical, hormonal and hemodynamic mechanisms are involved in the pathogenesis of TOD. Common to all these processes is an increased bioavailability of reactive oxygen species (ROS). Both in vitro and in vivo studies explored the role of mitochondrial oxidative stress as a mechanism involved in the pathogenesis of TOD in hypertension, especially focusing on atherosclerosis, heart disease, renal failure, cerebrovascular disease. Both dysfunction of mitochondrial proteins, such as uncoupling protein-2 (UCP2), superoxide dismutase (SOD) 2, peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α), calcium channels, and the interaction between mitochondria and other sources of ROS, such as NADPH oxidase, play an important role in the development of endothelial dysfunction, cardiac hypertrophy, renal and cerebral damage in hypertension. Commonly used anti-hypertensive drugs have shown protective effects against mitochondrial-dependent oxidative stress. Notably, few mitochondrial proteins can be considered therapeutic targets on their own. In fact, antioxidant therapies specifically targeted at mitochondria represent promising strategies to reduce mitochondrial dysfunction and related hypertensive TOD. In the present article, we discuss the role of mitochondrial oxidative stress as a contributing factor to hypertensive TOD development. We also provide an overview of mitochondria-based treatment strategies that may reveal useful to prevent TOD and reduce its progression.http://www.mdpi.com/1422-0067/16/1/823target organ damagehypertensionmitochondrial dysfunctionoxidative stress |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Speranza Rubattu Beniamino Pagliaro Giorgia Pierelli Caterina Santolamazza Sara Di Castro Silvia Mennuni Massimo Volpe |
spellingShingle |
Speranza Rubattu Beniamino Pagliaro Giorgia Pierelli Caterina Santolamazza Sara Di Castro Silvia Mennuni Massimo Volpe Pathogenesis of Target Organ Damage in Hypertension: Role of Mitochondrial Oxidative Stress International Journal of Molecular Sciences target organ damage hypertension mitochondrial dysfunction oxidative stress |
author_facet |
Speranza Rubattu Beniamino Pagliaro Giorgia Pierelli Caterina Santolamazza Sara Di Castro Silvia Mennuni Massimo Volpe |
author_sort |
Speranza Rubattu |
title |
Pathogenesis of Target Organ Damage in Hypertension: Role of Mitochondrial Oxidative Stress |
title_short |
Pathogenesis of Target Organ Damage in Hypertension: Role of Mitochondrial Oxidative Stress |
title_full |
Pathogenesis of Target Organ Damage in Hypertension: Role of Mitochondrial Oxidative Stress |
title_fullStr |
Pathogenesis of Target Organ Damage in Hypertension: Role of Mitochondrial Oxidative Stress |
title_full_unstemmed |
Pathogenesis of Target Organ Damage in Hypertension: Role of Mitochondrial Oxidative Stress |
title_sort |
pathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stress |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2014-12-01 |
description |
Hypertension causes target organ damage (TOD) that involves vasculature, heart, brain and kidneys. Complex biochemical, hormonal and hemodynamic mechanisms are involved in the pathogenesis of TOD. Common to all these processes is an increased bioavailability of reactive oxygen species (ROS). Both in vitro and in vivo studies explored the role of mitochondrial oxidative stress as a mechanism involved in the pathogenesis of TOD in hypertension, especially focusing on atherosclerosis, heart disease, renal failure, cerebrovascular disease. Both dysfunction of mitochondrial proteins, such as uncoupling protein-2 (UCP2), superoxide dismutase (SOD) 2, peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α), calcium channels, and the interaction between mitochondria and other sources of ROS, such as NADPH oxidase, play an important role in the development of endothelial dysfunction, cardiac hypertrophy, renal and cerebral damage in hypertension. Commonly used anti-hypertensive drugs have shown protective effects against mitochondrial-dependent oxidative stress. Notably, few mitochondrial proteins can be considered therapeutic targets on their own. In fact, antioxidant therapies specifically targeted at mitochondria represent promising strategies to reduce mitochondrial dysfunction and related hypertensive TOD. In the present article, we discuss the role of mitochondrial oxidative stress as a contributing factor to hypertensive TOD development. We also provide an overview of mitochondria-based treatment strategies that may reveal useful to prevent TOD and reduce its progression. |
topic |
target organ damage hypertension mitochondrial dysfunction oxidative stress |
url |
http://www.mdpi.com/1422-0067/16/1/823 |
work_keys_str_mv |
AT speranzarubattu pathogenesisoftargetorgandamageinhypertensionroleofmitochondrialoxidativestress AT beniaminopagliaro pathogenesisoftargetorgandamageinhypertensionroleofmitochondrialoxidativestress AT giorgiapierelli pathogenesisoftargetorgandamageinhypertensionroleofmitochondrialoxidativestress AT caterinasantolamazza pathogenesisoftargetorgandamageinhypertensionroleofmitochondrialoxidativestress AT saradicastro pathogenesisoftargetorgandamageinhypertensionroleofmitochondrialoxidativestress AT silviamennuni pathogenesisoftargetorgandamageinhypertensionroleofmitochondrialoxidativestress AT massimovolpe pathogenesisoftargetorgandamageinhypertensionroleofmitochondrialoxidativestress |
_version_ |
1725231874494693376 |